269 related articles for article (PubMed ID: 15723810)
1. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.
Zwart W; Griekspoor A; Kuijl C; Marsman M; van Rheenen J; Janssen H; Calafat J; van Ham M; Janssen L; van Lith M; Jalink K; Neefjes J
Immunity; 2005 Feb; 22(2):221-33. PubMed ID: 15723810
[TBL] [Abstract][Full Text] [Related]
2. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
3. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
[TBL] [Abstract][Full Text] [Related]
4. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
[TBL] [Abstract][Full Text] [Related]
5. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
6. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
[TBL] [Abstract][Full Text] [Related]
7. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
8. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
9. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases.
Lem L; Riethof DA; Scidmore-Carlson M; Griffiths GM; Hackstadt T; Brodsky FM
J Immunol; 1999 Jan; 162(1):523-32. PubMed ID: 9886429
[TBL] [Abstract][Full Text] [Related]
10. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
11. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
Belmares MP; Busch R; Mellins ED; McConnell HM
Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
[TBL] [Abstract][Full Text] [Related]
12. 3-D Structure of multilaminar lysosomes in antigen presenting cells reveals trapping of MHC II on the internal membranes.
Murk JL; Lebbink MN; Humbel BM; Geerts WJ; Griffith JM; Langenberg DM; Verreck FA; Verkleij AJ; Koster AJ; Geuze HJ; Kleijmeer MJ
Traffic; 2004 Dec; 5(12):936-45. PubMed ID: 15522096
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HLA-DM/HLA-DR interface.
Davies MN; Lamikanra A; Sansom CE; Flower DR; Moss DS; Travers PJ
Mol Immunol; 2008 Feb; 45(4):1063-70. PubMed ID: 17870168
[TBL] [Abstract][Full Text] [Related]
14. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
Ferrari G; Knight AM; Watts C; Pieters J
J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
[TBL] [Abstract][Full Text] [Related]
15. Dynamics within tetraspanin pairs affect MHC class II expression.
Hoorn Tv; Paul P; Janssen L; Janssen H; Neefjes J
J Cell Sci; 2012 Jan; 125(Pt 2):328-39. PubMed ID: 22302999
[TBL] [Abstract][Full Text] [Related]
16. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
Chamuleau ME; Souwer Y; Van Ham SM; Zevenbergen A; Westers TM; Berkhof J; Meijer CJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Res; 2004 Aug; 64(16):5546-50. PubMed ID: 15313888
[TBL] [Abstract][Full Text] [Related]
17. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments.
Haug M; Schepp CP; Kalbacher H; Dannecker GE; Holzer U
Eur J Immunol; 2007 Apr; 37(4):1053-63. PubMed ID: 17357109
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation.
Ma C; Blum JS
J Immunol; 1997 Jan; 158(1):1-4. PubMed ID: 8977167
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
van Lith M; van Ham M; Neefjes J
Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
[TBL] [Abstract][Full Text] [Related]
20. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
